Neoplasms and Medical Oncology

At Hospital Lusiadas Porto, clinical research in neoplasms focuses on advanced breast cancer and the search for better ways to control disease progression. The trials are designed to evaluate the effectiveness and safety of new treatment approaches for people with hormone receptor-positive, HER2-negative breast cancer.

  • Assessing new cancer therapy combinations for advanced breast cancer
  • Studying treatment effectiveness in breast cancer care
  • Evaluating safety alongside potential benefit for patients with neoplastic disease

These studies reflect a strong interest in improving outcomes in oncology through more targeted and effective treatment options.

Female Urogenital Diseases

Research in female urogenital diseases at this Porto site includes work on overactive bladder, with attention to both symptom relief and patient experience. The trial activity aims to explore whether a new treatment system can offer a practical and acceptable option for people living with bladder control problems.

  • Investigating a new approach for overactive bladder
  • Looking at symptom management and patient satisfaction
  • Gathering feedback on ease of use and treatment acceptability

This area combines urology and patient-centered care, with an emphasis on improving everyday quality of life for individuals affected by bladder symptoms.

Male Urogenital Diseases and Related Urologic Care

Although the current trial portfolio is small, the site’s coverage of male urogenital diseases and broader urologic research indicates interest in conditions affecting the urinary system. The ongoing studies contribute to understanding how new therapies and delivery systems may improve treatment experience and clinical benefit across urinary disorders.

  • Exploring treatment options relevant to urinary tract disorders
  • Supporting research into bladder health and related symptoms
  • Advancing practical care approaches in urology

With Medical Oncology as the main department, the site shows a focused but diverse interest in both cancer care and urinary health research.